Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 852


Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet].

Chou R, Dana T, Bougatsos C, Fu R, Blazina I, Gleitsmann K, Rugge JB.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct.


Radical prostatectomy versus watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Steineck G, Adami HO, Johansson JE; SPCG-4 Investigators.

N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.


Radical prostatectomy versus watchful waiting for prostate cancer.

Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006590. doi: 10.1002/14651858.CD006590.pub2. Review.


Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.

Gillessen S, Templeton A, Marra G, Kuo YF, Valtorta E, Shahinian VB.

J Natl Cancer Inst. 2010 Dec 1;102(23):1760-70. doi: 10.1093/jnci/djq419. Epub 2010 Nov 10.


Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, Krahn M, Fleshner NE, Warde P, Canning SD, Klotz L, Naglie G.

J Clin Oncol. 2010 Dec 1;28(34):5038-45. doi: 10.1200/JCO.2010.29.8091. Epub 2010 Nov 1.


Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.

Hadley J, Yabroff KR, Barrett MJ, Penson DF, Saigal CS, Potosky AL.

J Natl Cancer Inst. 2010 Dec 1;102(23):1780-93. doi: 10.1093/jnci/djq393. Epub 2010 Oct 13.


Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.

Holmström B, Holmberg E, Egevad L, Adolfsson J, Johansson JE, Hugosson J, Stattin P; National Prostate Cancer Register of Sweden.

J Urol. 2010 Oct;184(4):1322-7. doi: 10.1016/j.juro.2010.06.008. Epub 2010 Aug 17.


Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.

Cooperberg MR, Vickers AJ, Broering JM, Carroll PR.

Cancer. 2010 Nov 15;116(22):5226-34. doi: 10.1002/cncr.25456. Erratum in: Cancer. 2011 Jun 15;117(12):2825.


Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.

Shao YH, Albertsen PC, Roberts CB, Lin Y, Mehta AR, Stein MN, DiPaola RS, Lu-Yao GL.

Arch Intern Med. 2010 Jul 26;170(14):1256-61. doi: 10.1001/archinternmed.2010.221.


Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.

Alibhai SM, Duong-Hua M, Cheung AM, Sutradhar R, Warde P, Fleshner NE, Paszat L.

J Urol. 2010 Sep;184(3):918-23. doi: 10.1016/j.juro.2010.04.068.


Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H.

Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.


Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate.

Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A.

J Endourol. 2010 Jul;24(7):1123-9. doi: 10.1089/end.2010.0130.


Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J; National Prostate Cancer Register (NPCR) of Sweden.

J Natl Cancer Inst. 2010 Jul 7;102(13):950-8. doi: 10.1093/jnci/djq154. Epub 2010 Jun 18.


Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy.

Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR.

BJU Int. 2010 Dec;106(11):1734-8. doi: 10.1111/j.1464-410X.2010.09333.x.


Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E.

BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.


Improving decisions for men with prostate cancer: translational outcomes research.

Bergman J, Kwan L, Litwin MS.

J Urol. 2010 Jun;183(6):2186-92. doi: 10.1016/j.juro.2010.02.006.


Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

Talcott JA, Rossi C, Shipley WU, Clark JA, Slater JD, Niemierko A, Zietman AL.

JAMA. 2010 Mar 17;303(11):1046-53. doi: 10.1001/jama.2010.287. Erratum in: JAMA. 2010 Apr 7;303(13):1257.


Early complication rates in a single-surgeon series of 2500 robotic-assisted radical prostatectomies: report applying a standardized grading system.

Coelho RF, Palmer KJ, Rocco B, Moniz RR, Chauhan S, Orvieto MA, Coughlin G, Patel VR.

Eur Urol. 2010 Jun;57(6):945-52. doi: 10.1016/j.eururo.2010.02.001. Epub 2010 Feb 13.


Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.

Beydoun HA, Mohan R, Beydoun MA, Davis J, Lance R, Schellhammer P.

BJU Int. 2010 Aug;106(3):334-41. doi: 10.1111/j.1464-410X.2010.09209.x. Epub 2010 Feb 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk